FDA Panel to Decide on U.S. Distribution of Controversial Contraceptive Pill, EllaOne

A controversial, longer-lasting morning after pill has received the unanimous backing of a Food and Drug Administration panel of experts. The panel today recommended that ellaOne, a one-pill treatment that has proved effective in preventing pregnancy up to five days after unprotected intercourse, be approved for use in the United States. Although the FDA is not required to follow the panel's recommendation, it usually does. EllaOne, made by French drugmaker HRA Pharma, was approved for use...Full Story
Commenting on this article is closed.